Healthcare provider profile · identity verified

Christopher J Schmitt, M.D.

Family Practice · TACOMA, WA · NPI 1578616272

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	550	161
Lisinopril	Lisinopril	358	111
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	340	90
Oxycodone Hcl	Oxycodone Hcl	267	71
Losartan Potassium	Losartan Potassium	239	79
Levothyroxine Sodium	Levothyroxine Sodium	221	69
Simvastatin	Simvastatin	214	60
Amlodipine Besylate	Amlodipine Besylate	201	68
Rosuvastatin Calcium	Rosuvastatin Calcium	184	58
Metformin Hcl	Metformin Hcl	178	57
Albuterol Sulfate Hfa	Albuterol Sulfate	153	59
Pantoprazole Sodium	Pantoprazole Sodium	144	62
Trazodone Hcl	Trazodone Hcl	144	54
Gabapentin	Gabapentin	141	51
Tamsulosin Hcl	Tamsulosin Hcl	141	48
Furosemide	Furosemide	134	44
Pradaxa	Dabigatran Etexilate Mesylate	131	36
Lorazepam	Lorazepam	125	32
Duloxetine Hcl	Duloxetine Hcl	123	31
Metoprolol Succinate	Metoprolol Succinate	120	39
Metoprolol Tartrate	Metoprolol Tartrate	113	38
Potassium Chloride	Potassium Chloride	105	36
Glipizide	Glipizide	103	35
Allopurinol	Allopurinol	102	28
Tramadol Hcl	Tramadol Hcl	102	21
Atenolol	Atenolol	100	33
Sertraline Hcl	Sertraline Hcl	95	35
Omeprazole	Omeprazole	91	28
Finasteride	Finasteride	84	21
Hydrochlorothiazide	Hydrochlorothiazide	84	32
Pregabalin	Pregabalin	78	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	22
Warfarin Sodium	Warfarin Sodium	64	17
Terazosin Hcl	Terazosin Hcl	63	24
Metformin Hcl Er	Metformin Hcl	62	23
Mirtazapine	Mirtazapine	60	22
Fluoxetine Hcl	Fluoxetine Hcl	57	21
Pravastatin Sodium	Pravastatin Sodium	57	17
Ondansetron Odt	Ondansetron	52	17
Bupropion Xl	Bupropion Hcl	47	15
Clopidogrel	Clopidogrel Bisulfate	46	15
Escitalopram Oxalate	Escitalopram Oxalate	46	17
Meloxicam	Meloxicam	46	20
Alvesco	Ciclesonide	45	14
Wixela Inhub	Fluticasone Propion/Salmeterol	44	18
Tizanidine Hcl	Tizanidine Hcl	43	16
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Alendronate Sodium	Alendronate Sodium	41	20
Carvedilol	Carvedilol	41	15
Jardiance	Empagliflozin	41	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	15
Ozempic	Semaglutide	38	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Spiriva Respimat	Tiotropium Bromide	35	suppressed
Baclofen	Baclofen	34	13
Fluticasone Propionate	Fluticasone Propionate	34	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	34	11
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Methocarbamol	Methocarbamol	32	12
Topiramate	Topiramate	32	suppressed
Estradiol	Estradiol	31	17
Clobetasol Propionate	Clobetasol Propionate	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Prednisone	Prednisone	30	23
Buspirone Hcl	Buspirone Hcl	29	16
Donepezil Hcl	Donepezil Hcl	29	11
Famotidine	Famotidine	29	11
Humulin N	Insulin Nph Human Isophane	29	12
Alprazolam	Alprazolam	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	21
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Doxepin Hcl	Doxepin Hcl	25	suppressed
Metronidazole	Metronidazole	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Spironolactone	Spironolactone	24	11
Mometasone Furoate	Mometasone Furoate	23	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	22	suppressed
Lovastatin	Lovastatin	21	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	18	11
Eliquis	Apixaban	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	12
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Probenecid	Probenecid	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Digoxin	Digoxin	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error